Drug bosses doubt Amodei's 10-year cure claim

Drug company bosses doubt a claim by Anthropic chief Dario Amodei that AI will end major diseases within 10 years. Benzinga gathered their replies on the 13th of November 2026.

Anthropic, maker of the Claude AI models, is set to start trading its shares on the 19th of November.

The claim

In a video for investors released on the 10th of November, Amodei named cancer, Alzheimer's, heart disease and mental illness. He said they "will be relics of the past in, I think, less than a decade."

The replies

"I think that would be amazing and I think it's not likely," Eli Lilly chief executive Dave Ricks wrote on X. He said human trials are the slowest step.

Jeff Leiden, executive chairman of Vertex Pharmaceuticals, dismissed such timelines more bluntly, Benzinga reported.

The Vertex test

Vertex tested about 50 AI companies on about 10,000 compounds, Leiden said. None of them produced a working drug on its own, he said.

Why medicine is slow

A new drug now costs about 1.5 billion dollars and takes about 15 years, investor Elad Gil said on the No Priors podcast.

Below we break down the gap

Amodei gives AI less than 10 years to end these diseases. Gil's figure of about 15 years for one drug is 1.5 times that, by our arithmetic.

What is confirmed and what is not

Anthropic said in October that it has begun its own drug discovery work. It has not shown a new cure.

Key facts

Dario Amodei said major diseases could be gone in under 10 years.

Eli Lilly's Dave Ricks called that not likely.

Vertex said 50 AI firms produced no working drug on their own.

Anthropic shares are set to start trading on the 19th of November 2026.